| UniProt ID | 5HT2A_RAT | |
|---|---|---|
| UniProt AC | P14842 | |
| Protein Name | 5-hydroxytryptamine receptor 2A | |
| Gene Name | Htr2a | |
| Organism | Rattus norvegicus (Rat). | |
| Sequence Length | 471 | |
| Subcellular Localization |
Cell membrane Multi-pass membrane protein . Cell projection, axon . Cytoplasmic vesicle . Membrane, caveola . Cell projection, dendrite. Localizes to the postsynaptic thickening of axo-dendritic synapses.. |
|
| Protein Description | G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various drugs and psychoactive substances, including mescaline, psilocybin, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Beta-arrestin family members inhibit signaling via G proteins and mediate activation of alternative signaling pathways. Signaling activates phospholipase C and a phosphatidylinositol-calcium second messenger system that modulates the activity of phosphatidylinositol 3-kinase and promotes the release of Ca(2+) ions from intracellular stores. Affects neural activity, perception, cognition and mood. Plays a role in the regulation of behavior, including responses to anxiogenic situations and psychoactive substances. Plays a role in intestinal smooth muscle contraction, and may play a role in arterial vasoconstriction.. | |
| Protein Sequence | MEILCEDNISLSSIPNSLMQLGDGPRLYHNDFNSRDANTSEASNWTIDAENRTNLSCEGYLPPTCLSILHLQEKNWSALLTTVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAIWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVAFFIPLTIMVITYFLTIKSLQKEATLCVSDLSTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYAGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNENVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENRKPLQLILVNTIPALAYKSSQLQVGQKKNSQEDAEQTVDDCSMVTLGKQQSEENCTDNIETVNEKVSCV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 8 | N-linked_Glycosylation | MEILCEDNISLSSIP CCEECCCCCCHHHCC | 11.94 | - | |
| 38 | N-linked_Glycosylation | DFNSRDANTSEASNW CCCCCCCCCCHHHCC | 48.72 | - | |
| 44 | N-linked_Glycosylation | ANTSEASNWTIDAEN CCCCHHHCCEECCCC | 47.13 | - | |
| 51 | N-linked_Glycosylation | NWTIDAENRTNLSCE CCEECCCCCCCCCCC | 58.77 | - | |
| 54 | N-linked_Glycosylation | IDAENRTNLSCEGYL ECCCCCCCCCCCCCC | 27.07 | - | |
| 273 | Phosphorylation | TLCVSDLSTRAKLAS CEEECCHHHHHHHHH | 22.34 | 25403869 | |
| 274 | Phosphorylation | LCVSDLSTRAKLASF EEECCHHHHHHHHHC | 41.78 | 25403869 | |
| 277 | Ubiquitination | SDLSTRAKLASFSFL CCHHHHHHHHHCCCC | 41.10 | - | |
| 280 | Phosphorylation | STRAKLASFSFLPQS HHHHHHHHCCCCCCC | 31.68 | 19103592 | |
| 298 | Phosphorylation | SEKLFQRSIHREPGS HHHHHHHHHHCCCCC | 16.38 | 25403869 | |
| 314 | Phosphorylation | AGRRTMQSISNEQKA HCHHHHHHHCHHHHH | 19.70 | 19103592 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 314 | S | Phosphorylation | Kinase | RPS6KA3 | P51812 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of 5HT2A_RAT !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of 5HT2A_RAT !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of 5HT2A_RAT !! | ||||
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...